Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization

Biomaterials

Volumn 31, Issue 11, 2010, Pages 3054-3062

  Jay, Steven M ^a,c   Shepherd, Benjamin R ^b,c   Andrejecsk, Jillian W ^a   Kyriakides, Themis R ^a,b,c   Pober, Jordan S ^b,c   Saltzman, W Mark ^a,c  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Alginate; Angiogenesis; Collagen hydrogel; Controlled drug release; Growth factor; Tissue engineering

Indexed keywords

ANGIOGENESIS; APOPTOSIS; BENEFICIAL EFFECTS; CELL-BASED THERAPY; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; GROWTH FACTOR; MICRO-PARTICLES; MONOCYTE CHEMOTACTIC PROTEIN-1; POTENTIAL BENEFITS; RELEASE KINETICS; SMOOTH MUSCLE CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION; VESSEL FORMATION;

ALGINATE; BIOACTIVITY; BLOOD VESSEL PROSTHESES; CELL DEATH; COLLAGEN; ELECTRIC CONDUCTIVITY MEASUREMENT; EMPLOYMENT; HYDROGELS; IMAGE STORAGE TUBES; PEPTIDES; SELF ASSEMBLY; TISSUE ENGINEERING;

ENDOTHELIAL CELLS;

ALGINIC ACID; COLLAGEN; FIBRONECTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; HYDROGEL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULARIZATION;

ALGINATES; ANIMALS; BLOOD VESSELS; CELL SURVIVAL; CHEMOKINE CCL2; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; HUMANS; HYDROGELS; IMPLANTS, EXPERIMENTAL; MICE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 76749157843     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.01.014     Document Type: Article

References (50)

1. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., et al. Therapeutic angiogenesis - a single intraarterial bolus of vascular endothelial growth-factor augments revascularization in a rabbit ischemic hind-limb model. J Clin Invest 93 (1994) 662-670
2. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
3. Bhattacharya V., McSweeney P.A., Shi Q., Bruno B., Ishida A., Nash R., et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 95 (2000) 581-585
4. Lederman R.J., Mendelsohn F.O., Anderson R.D., Saucedo J.F., Tenaglia A.N., Hermiller J.B., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359 (2002) 2053-2058
5. Henry T.D., Annex B.H., McKendall G.R., Azrin M.A., Lopez J.J., Giordano F.J., et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107 (2003) 1359-1365
6. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., and Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
7. Jay S.M., Shepherd B., Bertram J.P., Pober J., and Saltzman W.M. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J 22 (2008) 2949-2956
8. Silva E., Kim E.S., Kong H., and Mooney D. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci USA 105 (2008) 14347-14352
9. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 (2001) 1029-1034
10. Cao R., Brakenhielm E., Pawliuk R., Wariaro D., Post M.J., Wahlberg E., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9 (2003) 604-613
11. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
12. Peirce S.M., Price R.J., and Skalak T.C. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol 286 (2004) H918-H925
13. Pike D.B., Cai S., Pomraning K.R., Firpo M.A., Fisher R.J., Shu X.Z., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27 (2006) 5242-5251
14. Freeman I., and Cohen S. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials (2009) 1-10
15. Rophael J.A., Craft R.O., Palmer J.A., Hussey A.J., Thomas G.P., Morrison W.A., et al. Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol 171 (2007) 2048-2057
16. Greenberg J.I., Shields D.J., Barillas S.G., Acevedo L.M., Murphy E., Huang J., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456 (2008) 809-813
17. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
18. Enis D.R., Shepherd B.R., Wang Y., Qasim A., Shanahan C.M., Weissberg P.L., et al. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc Natl Acad Sci U S A 102 (2005) 425-430
19. Schechner J.S., Nath A.K., Zheng L., Kluger M.S., Hughes C.C., Sierra-Honigmann M.R., et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A 97 (2000) 9191-9196
20. Shepherd B., Jay S.M., Saltzman W.M., Tellides G., and Pober J. Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. Tissue Eng Part A 15 (2009) 165-173
21. Pober J.S. Is host endothelium a silver lining for allografts?. Lancet 357 (2001) 2-3
22. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115 (2005) 572-583
23. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
24. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., and Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109 (2007) 4761-4768
25. Nor J.E., Christensen J., Mooney D.J., and Polverini P.J. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154 (1999) 375-384
26. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., and Jain R.K. Tissue engineering: creation of long-lasting blood vessels. Nature 428 (2004) 138-139
27. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3 (2008) 301-313
28. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., and Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80 (1997) 829-837
29. Selzman C.H., Miller S.A., Zimmerman M.A., Gamboni-Robertson F., Harken A.H., and Banerjee A. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol 283 (2002) H1455-H1461
30. Jay S.M., and Saltzman W.M. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J Control Release 134 (2009) 26-34
31. Rollins B.J. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2 (1996) 198-204
32. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005) 953-964
33. Peters M.C., Isenberg B.C., Rowley J.A., and Mooney D.J. Release from alginate enhances the biological activity of vascular endothelial growth factor. J Biomater Sci Polym Ed 9 (1998) 1267-1278
34. Capoccia B.J., Gregory A.D., and Link D.C. Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion. J Leukoc Biol 84 (2008) 760-768
35. Heilmann C., Kostic C., Giannone B., Grawitz A.B., Armbruster W., Lutter G., et al. Improvement of contractility accompanies angiogenesis rather than arteriogenesis in chronic myocardial ischemia. Vascul Pharmacol 44 (2006) 326-332
36. Fujii T., Yonemitsu Y., Onimaru M., Tanii M., Nakano T., Egashira K., et al. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol 26 (2006) 2483-2489
37. Davies N., Dobner S., Bezuidenhout D., Schmidt C., Beck M., Zisch A.H., et al. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 29 (2008) 3531-3538
38. Ozawa C.R., Banfi A., Glazer N.L., Thurston G., Springer M.L., Kraft P.E., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113 (2004) 516-527
39. Silva E.A., and Mooney D.J. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5 (2007) 590-598
40. Jay S.M., Skokos E., Laiwalla F., Krady M.M., and Kyriakides T.R. Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. Am J Pathol 171 (2007) 632-640
41. Kyriakides T.R., Foster M.J., Keeney G.E., Tsai A., Giachelli C.M., Clark-Lewis I., et al. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165 (2004) 2157-2166
42. Parenti A., Bellik L., Brogelli L., Filippi S., and Ledda F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286 (2004) H1978-H1984
43. Salcedo R., Ponce M.L., Young H.A., Wasserman K., Ward J.M., Kleinman H.K., et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96 (2000) 34-40
44. Niu J., Azfer A., Zhelyabovska O., Fatma S., and Kolattukudy P. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J Biol Chem 283 (2008) 14542-14551
45. Schecter A.D., Berman A.B., Yi L., Ma H., Daly C.M., Soejima K., et al. MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells. J Leukoc Biol 75 (2004) 1079-1085
46. Au P., Tam J., Duda D.G., Lin P.C., Munn L.L., Fukumura D., et al. Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo. Am J Pathol 175 (2009) 294-302
47. Suarez Y., Shepherd B.R., Rao D.A., and Pober J.S. Alloimmunity to human endothelial cells derived from cord blood progenitors. J Immunol 179 (2007) 7488-7496
48. Ehrbar M., Zeisberger S.M., Raeber G.P., Hubbell J.A., Schnell C., and Zisch A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 29 (2008) 1720-1729
49. van Royen N., Hoefer I., Buschmann I., Kostin S., Voskuil M., Bode C., et al. Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits. Cardiovasc Res 57 (2003) 178-185
50. Voskuil M., van Royen N., Hoefer I.E., Seidler R., Guth B.D., Bode C., et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol 284 (2003) H1422-H1428